{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:25:52Z","timestamp":1793780752473,"version":"4.6.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018778","name":"Al-Azhar University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018778","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Preterm birth remains a major contributor to neonatal morbidity and mortality worldwide. Oral dydrogesterone is used in some clinical settings for preterm birth prevention, despite uncertainty regarding its effectiveness. This systematic review aimed to evaluate the efficacy and safety of oral dydrogesterone compared with placebo in women at risk of preterm birth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review and meta-analysis in accordance with PRISMA guidelines. Randomized controlled trials comparing oral dydrogesterone with placebo in pregnant women at risk of preterm birth were included; non-randomized, observational, and animal studies were excluded. We searched PubMed, Cochrane Library, Web of Science, and Scopus from inception to December 2024. Risk of bias was assessed using the Cochrane Risk of Bias tool. Random-effects meta-analyses were performed where appropriate. We evaluated Certainty of evidence using the GRADE approach, and trial sequential analysis (TSA) was conducted to assess the conclusiveness of the evidence. The review was registered in PROSPERO (CRD42025639288).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five randomized controlled trials involving 436 participants were included. Compared with the placebo, dydrogesterone showed a non-significant trend toward increased gestational age at delivery (mean difference, 0.42 weeks; 95% CI -0.70 to 1.55) and a reduced risk of neonatal intensive care unit admission (risk ratio, 0.74; 95% CI 0.47 to 1.18). No statistically significant differences were observed for other maternal or neonatal outcomes. The certainty of evidence was rated as low or very low for most outcomes using GRADE. TSA demonstrated that the accumulated evidence remains underpowered and insufficient to draw firm conclusions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Current randomized evidence does not demonstrate a statistically or clinically meaningful benefit of oral dydrogesterone over placebo in preventing preterm birth or improving maternal or neonatal outcomes. The low to very low certainty of evidence and inconclusive TSA findings indicate that the existing evidence base is insufficient to support clinical recommendations. Larger, high-quality randomized trials are required before oral dydrogesterone can be considered for routine clinical use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-026-08747-5","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:55:02Z","timestamp":1771894502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of oral dydrogesterone compared to placebo in reducing the risk of preterm birth: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6006-1227","authenticated-orcid":false,"given":"Sohieb","family":"Hedawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahed","family":"Aldalahmeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman E.","family":"Labeeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman A.","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0078-0310","authenticated-orcid":false,"given":"Ahmed","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Menshawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"8747_CR1","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1126\/SCIENCE.1251816","volume":"345","author":"R Romero","year":"2014","unstructured":"Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science. 2014;345:760\u20135. https:\/\/doi.org\/10.1126\/SCIENCE.1251816.","journal-title":"Science"},{"key":"8747_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/J.SINY.2015.12.011","volume":"21","author":"HA Frey","year":"2016","unstructured":"Frey HA, Klebanoff MA. The epidemiology, etiology, and costs of preterm birth. Semin Fetal Neonatal Med. 2016;21:68\u201373. https:\/\/doi.org\/10.1016\/J.SINY.2015.12.011.","journal-title":"Semin Fetal Neonatal Med"},{"key":"8747_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4755-10-S1-S2","author":"H Blencowe","year":"2013","unstructured":"Blencowe H, Cousens S, Chou D, Oestergaard M, Say L, Moller AB, et al. Born too soon: the global epidemiology of 15\u00a0million preterm births. Reprod Health. 2013. https:\/\/doi.org\/10.1186\/1742-4755-10-S1-S2.","journal-title":"Reprod Health"},{"key":"8747_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-10-S1-S1","author":"JE Lawn","year":"2010","unstructured":"Lawn JE, Gravett MG, Nunes TM, Rubens CE, Stanton C. Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data. BMC Pregnancy Childbirth. 2010. https:\/\/doi.org\/10.1186\/1471-2393-10-S1-S1.","journal-title":"BMC Pregnancy Childbirth"},{"key":"8747_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/J.SINY.2015.12.007","volume":"21","author":"MS Harrison","year":"2016","unstructured":"Harrison MS, Goldenberg RL. Global burden of prematurity. Semin Fetal Neonatal Med. 2016;21:74\u20139. https:\/\/doi.org\/10.1016\/J.SINY.2015.12.007.","journal-title":"Semin Fetal Neonatal Med"},{"key":"8747_CR6","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1097\/AOG.0000000000001711","volume":"128","author":"HN Simhan","year":"2016","unstructured":"Simhan HN. Practice bulletin 171: management of preterm labor. Obstet Gynecol. 2016;128:e155\u201364. https:\/\/doi.org\/10.1097\/AOG.0000000000001711.","journal-title":"Obstet Gynecol"},{"key":"8747_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1517\/14656566.2014.889684","volume":"15","author":"EOG Van Vliet","year":"2014","unstructured":"Van Vliet EOG, Boormans EM, De Lange TS, Mol BW, Oudijk MA. Preterm labor: current pharmacotherapy options for tocolysis. Expert Opin Pharmacother. 2014;15:787\u201397. https:\/\/doi.org\/10.1517\/14656566.2014.889684.","journal-title":"Expert Opin Pharmacother"},{"key":"8747_CR8","unstructured":"Progesterone supplementation and the prevention of preterm birth - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/22102929\/. Accessed 14 Jan 2025."},{"key":"8747_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS23031333","author":"R Raghupathy","year":"2022","unstructured":"Raghupathy R, Szekeres-Bartho J. Progesterone: a unique hormone with immunomodulatory roles in pregnancy. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/IJMS23031333.","journal-title":"Int J Mol Sci"},{"key":"8747_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/JCM10194511","author":"GC Di Renzo","year":"2021","unstructured":"Di Renzo GC, Tosto V, Tsibizova V, Fonseca E. Prevention of preterm birth with progesterone. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/JCM10194511.","journal-title":"J Clin Med"},{"key":"8747_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.5468\/OGS.2017.60.5.405","volume":"60","author":"SJ Choi","year":"2017","unstructured":"Choi SJ. Use of progesterone supplement therapy for prevention of preterm birth: review of literatures. Obstet Gynecol Sci. 2017;60:405\u201320. https:\/\/doi.org\/10.5468\/OGS.2017.60.5.405.","journal-title":"Obstet Gynecol Sci"},{"key":"8747_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/J.JSBMB.2005.08.013","volume":"97","author":"MH Omar","year":"2005","unstructured":"Omar MH, Mashita MK, Lim PS, Jamil MA. Dydrogesterone in threatened abortion: pregnancy outcome. J Steroid Biochem Mol Biol. 2005;97:421\u20135. https:\/\/doi.org\/10.1016\/J.JSBMB.2005.08.013.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"8747_CR13","doi-asserted-by":"publisher","unstructured":"Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW et al. Classification and pharmacology of progestins. Maturitas. 2003;46 SUPPL. 1:7. https:\/\/doi.org\/10.1016\/j.maturitas.2003.09.014.","DOI":"10.1016\/j.maturitas"},{"key":"8747_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/J.STEROIDS.2011.02.043","volume":"76","author":"TL Ri\u017ener","year":"2011","unstructured":"Ri\u017ener TL, Bro\u017ei\u010d P, Doucette C, Turek-Etienne T, M\u00fcller-Vieira U, Sonneveld E, et al. Selectivity and potency of the retroprogesterone dydrogesterone in vitro. Steroids. 2011;76:607\u201315. https:\/\/doi.org\/10.1016\/J.STEROIDS.2011.02.043.","journal-title":"Steroids"},{"key":"8747_CR15","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/S0015-0282(16)49880-8","volume":"46","author":"RJB King","year":"1986","unstructured":"King RJB, Whitehead MI. Assessment of the potency of orally administered progestins in women. Fertil Steril. 1986;46:1062\u20136. https:\/\/doi.org\/10.1016\/S0015-0282(16)49880-8.","journal-title":"Fertil Steril"},{"key":"8747_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3109\/09513590.2015.1115832","volume":"32","author":"N Podzolkova","year":"2016","unstructured":"Podzolkova N, Tatarchuk T, Doshchanova A, Eshimbetova G, Pexman-Fieth C. Dydrogesterone treatment for menstrual-cycle regularization in routine clinical practice: a multicenter observational study. Gynecol Endocrinol. 2016;32:246\u20139. https:\/\/doi.org\/10.3109\/09513590.2015.1115832.","journal-title":"Gynecol Endocrinol"},{"key":"8747_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1515\/HMBCI-2019-0067","volume":"42","author":"HJA Carp","year":"2020","unstructured":"Carp HJA. Progestogens in luteal support. Horm Mol Biol Clin Investig. 2020;42:143\u20138. https:\/\/doi.org\/10.1515\/HMBCI-2019-0067.","journal-title":"Horm Mol Biol Clin Investig"},{"key":"8747_CR18","doi-asserted-by":"publisher","unstructured":"Mueck AO, Seeger H, B\u00fchling KJ. Use of dydrogesterone in hormone replacement therapy. Maturitas. 2009;65(SUPPL 1). https:\/\/doi.org\/10.1016\/j.maturitas.2009.09.013.","DOI":"10.1016\/j.maturitas.2009.09.013"},{"key":"8747_CR19","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.18203\/2320-1770.IJRCOG20242813","volume":"13","author":"J Tank","year":"2024","unstructured":"Tank J, Gupte S, Mahapatra PC, Reddy J, Mittal P, Mukhopadhyay AK, et al. Dydrogesterone use in recurrent pregnancy loss and luteal phase insufficiency: a knowledge, attitude, and practice survey amongst Indian obstetricians and gynaecologists. Int J Reprod Contracept Obstet Gynecol. 2024;13:2795\u2013800. https:\/\/doi.org\/10.18203\/2320-1770.IJRCOG20242813.","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"8747_CR20","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1055\/S-0029-1215432","volume":"26","author":"ZT Henderson","year":"2009","unstructured":"Henderson ZT, Power ML, Berghella V, Lackritz EM, Schulkin J. Attitudes and practices regarding use of progesterone to prevent preterm births. Am J Perinatol. 2009;26:529\u201336. https:\/\/doi.org\/10.1055\/S-0029-1215432.","journal-title":"Am J Perinatol"},{"key":"8747_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135. https:\/\/doi.org\/10.1186\/1471-2288-14-135.","journal-title":"BMC Med Res Methodol"},{"key":"8747_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0028-2243(91)90118-5","volume":"40","author":"G Noblot","year":"1991","unstructured":"Noblot G, Audra P, Dargent D, Faguer B, Mellier G. The use of micronized progesterone in the treatment of menace of preterm delivery. Eur J Obstet Gynecol Reprod Biol. 1991;40:203\u20139. https:\/\/doi.org\/10.1016\/0028-2243(91)90118-5.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"8747_CR23","doi-asserted-by":"publisher","unstructured":"Dodd JM, Jones L, Flenady V, Crowther CA. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database Syst Rev. 2013;2013. https:\/\/doi.org\/10.1002\/14651858.CD004947.PUB3.","DOI":"10.1002\/14651858.CD004947.PUB3"},{"key":"8747_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/1471-0528.13061","volume":"122","author":"B Martinez De Tejada","year":"2015","unstructured":"Martinez De Tejada B, Karolinski A, Ocampo MC, Laterra C, H\u00f6sli I, Fern\u00e1ndez D, et al. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial. BJOG. 2015;122:80\u201391. https:\/\/doi.org\/10.1111\/1471-0528.13061.","journal-title":"BJOG"},{"key":"8747_CR25","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1016\/S0140-6736(09)60947-8","volume":"373","author":"JE Norman","year":"2009","unstructured":"Norman JE, Mackenzie F, Owen P, Mactier H, Hanretty K, Cooper S, et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet. 2009;373:2034\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(09)60947-8.","journal-title":"Lancet"},{"key":"8747_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/J.IJGO.2015.06.058","volume":"132","author":"AC Eke","year":"2016","unstructured":"Eke AC, Chalaan T, Shukr G, Eleje GU, Okafor CI. A systematic review and meta-analysis of progestogen use for maintenance tocolysis after preterm labor in women with intact membranes. Int J Gynaecol Obstet. 2016;132:11\u20136. https:\/\/doi.org\/10.1016\/J.IJGO.2015.06.058.","journal-title":"Int J Gynaecol Obstet"},{"key":"8747_CR27","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1056\/NEJMOA067815","volume":"357","author":"EB Fonseca","year":"2007","unstructured":"Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med. 2007;357:462\u20139. https:\/\/doi.org\/10.1056\/NEJMOA067815.","journal-title":"N Engl J Med"},{"key":"8747_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/UOG.9017","volume":"38","author":"SS Hassan","year":"2011","unstructured":"Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011;38:18. https:\/\/doi.org\/10.1002\/UOG.9017.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"8747_CR29","doi-asserted-by":"publisher","first-page":"124e1","DOI":"10.1016\/J.AJOG.2011.12.003","volume":"206","author":"R Romero","year":"2012","unstructured":"Romero R, Nicolaides K, Conde-Agudelo A, Tabor A, O\u2019Brien JM, Cetingoz E, et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol. 2012;206:124e1. https:\/\/doi.org\/10.1016\/J.AJOG.2011.12.003.","journal-title":"Am J Obstet Gynecol"},{"key":"8747_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/J.MEFS.2010.03.007","volume":"15","author":"M Ibrahim","year":"2010","unstructured":"Ibrahim M, Mohamed Ramy AR, Younis MAF. Progesterone supplementation for prevention of preterm labor: a randomized controlled trial. Middle East Fertil Soc J. 2010;15:39\u201341. https:\/\/doi.org\/10.1016\/J.MEFS.2010.03.007.","journal-title":"Middle East Fertil Soc J"},{"key":"8747_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2217\/WHE.11.78","volume":"8","author":"S Gupta","year":"2012","unstructured":"Gupta S, Roman AS. 17-\u03b1 hydroxyprogesterone caproate for the prevention of preterm birth. Womens Health (Lond). 2012;8:21\u201330. https:\/\/doi.org\/10.2217\/WHE.11.78.","journal-title":"Womens Health (Lond)"},{"key":"8747_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-015-0024-z","volume":"15","author":"PT von Hippel","year":"2015","unstructured":"von Hippel PT. The heterogeneity statistic I2 can be biased in small meta-analyses. BMC Med Res Methodol. 2015;15:35. https:\/\/doi.org\/10.1186\/s12874-015-0024-z.","journal-title":"BMC Med Res Methodol"},{"key":"8747_CR33","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796021000664","volume":"30","author":"P Cuijpers","year":"2021","unstructured":"Cuijpers P, Griffin JW, Furukawa TA. The lack of statistical power of subgroup analyses in meta-analyses: a cautionary note. Epidemiol Psychiatr Sci. 2021;30:e78. https:\/\/doi.org\/10.1017\/S2045796021000664.","journal-title":"Epidemiol Psychiatr Sci"},{"key":"8747_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.13863","volume":"155","author":"B Jacobsson","year":"2021","unstructured":"Jacobsson B, Simpson JL. FIGO good practice recommendations for reducing preterm birth and improving child outcomes. Int J Gynaecol Obstet. 2021;155:1\u20134. https:\/\/doi.org\/10.1002\/ijgo.13863.","journal-title":"Int J Gynaecol Obstet"},{"key":"8747_CR35","unstructured":"National Institute for Health and Care Excellence (NICE). Preterm labour and birth: NICE Guideline 25 (NG25). London: National Institute for Health and Care Excellence; 2015. ISBN: 978-1-4731-1529-3. Available from: labour and birth NICE guideline. 2015. https:\/\/www.nice.org.uk\/guidance\/ng25."},{"key":"8747_CR36","unstructured":"Preterm birth. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/preterm-birth. Accessed 21 Nov 2025."},{"key":"8747_CR37","unstructured":"Page MJ, Higgins JP, Sterne JAC. Chapter 13: Assessing risk of bias due to missing evidence in a meta-analysis [last updated August 2024]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024. Available from https:\/\/cochrane.org\/handbook."},{"key":"8747_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-022-04509-1","volume":"22","author":"F Alizadeh","year":"2022","unstructured":"Alizadeh F, Mahmoudinia M, Mirteimoori M, Pourali L, Niroumand S. Comparison of oral Dydrogesterone and 17-\u03b1 hydroxyprogesterone caprate in the prevention of preterm birth. BMC Pregnancy Childbirth. 2022;22:167. https:\/\/doi.org\/10.1186\/s12884-022-04509-1.","journal-title":"BMC Pregnancy Childbirth"},{"key":"8747_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep20638","volume":"6","author":"W Areeruk","year":"2016","unstructured":"Areeruk W, Phupong V. A randomized, double blinded, placebo controlled trial of oral dydrogesterone supplementation in the management of preterm labor. Sci Rep. 2016;6:20638. https:\/\/doi.org\/10.1038\/srep20638.","journal-title":"Sci Rep"},{"key":"8747_CR40","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1007\/s43032-023-01249-1","volume":"30","author":"H Keshtmandi","year":"2023","unstructured":"Keshtmandi H, Mirmohammadkhani M, Rahmanian M. Adjuvant treatment with oral dydrogesterone in the prevention of preterm labor: a randomized, double-blinded, placebo-controlled trial. Reprod Sci. 2023;30:3037\u201345. https:\/\/doi.org\/10.1007\/s43032-023-01249-1.","journal-title":"Reprod Sci"},{"key":"8747_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12884-021-03562-6","volume":"21","author":"S Thongchan","year":"2021","unstructured":"Thongchan S, Phupong V. Oral dydrogesterone as an adjunctive therapy in the management of preterm labor: a randomized, double blinded, placebo-controlled trial. BMC Pregnancy Childbirth. 2021;21:90. https:\/\/doi.org\/10.1186\/s12884-021-03562-6.","journal-title":"BMC Pregnancy Childbirth"},{"key":"8747_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22038\/IJOGI.2019.14184","volume":"22","author":"M Lotfalizadeh","year":"2019","unstructured":"Lotfalizadeh M, Khademi Z, Maleki A, Najafi MN. Comparison of the duration of pregnancy in administration of progesterone suppository and Duphaston tablet in pregnant women with preterm labor after stopping delivery process. Iran J Obstet Gynecol Infertil. 2019;22:1\u201311. https:\/\/doi.org\/10.22038\/IJOGI.2019.14184.","journal-title":"Iran J Obstet Gynecol Infertil"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-08747-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-08747-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-08747-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:44:10Z","timestamp":1781635450000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-08747-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8747"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-08747-5","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study did not involve human participants or animal experiments requiring ethics approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"222"}}